Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MEDICINOVA INCMNOV · Entity 7011 | Chief Medical Officer | January 16, 2026 | January 20, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MEDICINOVA INC
Report date January 16, 2026 · Filed January 20, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.10 · Expires 2035-01-06 | Direct | 350,000 |
Reported balance
After 2026-01-16 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-01-16 · Grant · Acquired 350,000 · Balance 350,000 F1: On January 7, 2025, the reporting person was granted an option to purchase 350,000 shares of common stock. The option vests based on the satisfaction of certain performance criteria for the fiscal year ended December 31, 2025. Such performance criteria for 2025 were met, resulting in full vesting of the option. |
Filing footnotes · ownership attribution and instrument terms
F1: On January 7, 2025, the reporting person was granted an option to purchase 350,000 shares of common stock. The option vests based on the satisfaction of certain performance criteria for the fiscal year ended December 31, 2025. Such performance criteria for 2025 were met, resulting in full vesting of the option.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 16, 2026 Filed Jan 20, 2026 22:04 UTC | MEDICINOVA INC MNOV · Entity 7011 | GrantEmployee Stock Option (Right to Buy) · Derivative | 350,000 | $0.00 Strike: $2.10 | $0.00 |
DisclosureSEC source: 0001683168-26-000430 · ownership.xml · derivative · entry 1 Matsuda Kazuko · CIK 0001531140 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 350,000 Underlying: Common Stock · 350,000 shares Expires 2035-01-06 F1 · balance_after: On January 7, 2025, the reporting person was granted an option to purchase 350,000 shares of common stock. The option vests based on the satisfaction of certain performance criteria for the fiscal year ended December 31, 2025. Such performance criteria for 2025 were met, resulting in full vesting of the option. Read SEC document |
| February 12, 2025 Filed Feb 14, 2025 21:52 UTC | MEDICINOVA INC MNOV · Entity 7011 | GrantEmployee Stock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $1.84 | $0.00 |
DisclosureSEC source: 0001683168-25-001049 · ownership.xml · derivative · entry 1 Matsuda Kazuko · CIK 0001531140 · Director · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2035-02-11 F1 · derivative.exercise_date: The option vests over a period of one year in equal monthly installments from the 2/12/2025 date of grant. Read SEC document |
| January 07, 2025 Filed Jan 10, 2025 21:00 UTC | MEDICINOVA INC MNOV · Entity 7011 | GrantEmployee Stock Option (Right to Buy) · Derivative | 300,000 | $0.00 Strike: $1.52 | $0.00 |
DisclosureSEC source: 0001683168-25-000217 · ownership.xml · derivative · entry 1 Matsuda Kazuko · CIK 0001531140 · Director · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 300,000 shares Expires 2034-01-17 F1 · balance_after: On January 18, 2024, the reporting person was granted an option to purchase 300,000 shares of common stock. The option vests based on the satisfaction of certain performance criteria for the fiscal year ended December 31, 2024. Such performance criteria for 2024 were met, resulting in full vesting of the option. Read SEC document |
| January 09, 2024 Filed Jan 11, 2024 21:52 UTC | MEDICINOVA INC MNOV · Entity 7011 | GrantEmployee Stock Option (Right to Buy) · Derivative | 157,500 | $0.00 Strike: $2.40 | $0.00 |
DisclosureSEC source: 0001683168-24-000223 · ownership.xml · derivative · entry 1 Matsuda Kazuko · CIK 0001531140 · Director · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 157,500 Underlying: Common Stock · 157,500 shares Expires 2033-01-31 F1 · balance_after: On February 1, 2023, the reporting person was granted an option to purchase 225,000 shares of common stock. The option vests based on the satisfaction of certain performance criteria for the fiscal year ended December 31, 2023. Such performance criteria for 2023 were achieved at the 70% attainment level, resulting in vesting of the option as to 157,500 shares. Read SEC document |
| January 23, 2023 Filed Jan 25, 2023 22:16 UTC | MEDICINOVA INC MNOV · Entity 7011 | GrantEmployee Stock Option (Right to Buy) · Derivative | 149,625 | $0.00 Strike: $2.25 | $0.00 |
DisclosureSEC source: 0001683168-23-000341 · ownership.xml · derivative · entry 1 Matsuda Kazuko · CIK 0001531140 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,625 Underlying: Common Stock · 149,625 shares Expires 2032-01-26 F1 · balance_after: On January 27, 2022, the reporting person was granted an option to purchase 157,500 shares of common stock. The option vests based on the satisfaction of certain performance criteria for the fiscal year ended December 31, 2022. Such performance criteria for 2022 were achieved at the 95% attainment level, resulting in vesting of the option as to 149,625 shares. Read SEC document |
| January 27, 2022 Filed Feb 1, 2022 02:00 UTC | MEDICINOVA INC MNOV · Entity 7011 | GrantEmployee Stock Option (Right to Buy) · Derivative | 192,500 | $0.00 Strike: $5.92 | $0.00 |
DisclosureSEC source: 0001683168-22-000595 · ownership.xml · derivative · entry 1 Matsuda Kazuko · CIK 0001531140 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 192,500 Underlying: Common Stock · 192,500 shares Expires 2031-02-17 F1 · balance_after: On February 18, 2021, the reporting person was granted an option to purchase 350,000 shares of common stock. The option vests based on the satisfaction of certain performance criteria for the fiscal year ended December 31, 2021. Such performance criteria for 2021 were achieved at the 55% attainment level, resulting in vesting of the option as to 192,500 shares. Read SEC document |
| August 23, 2021 Filed Aug 25, 2021 11:52 UTC | MEDICINOVA INC MNOV · Entity 7011 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 60,000 | $0.00 Strike: $2.30 | $0.00 |
DisclosureSEC source: 0001683168-21-003893 · ownership.xml · derivative · entry 2 Matsuda Kazuko · CIK 0001531140 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 60,000 shares Expires 2021-08-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option vested over a period of 4 years in equal monthly installments from the 9/1/2011 date of grant and is now fully vested. Read SEC document |
| August 23, 2021 Filed Aug 25, 2021 11:52 UTC | MEDICINOVA INC MNOV · Entity 7011 | Exercise / conversionCommon Stock | 60,000 | $2.30 | $138,000.00 |
DisclosureSEC source: 0001683168-21-003893 · ownership.xml · nonDerivative · entry 1 Matsuda Kazuko · CIK 0001531140 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 322,996 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 24, 2021 Filed Jun 28, 2021 20:50 UTC | MEDICINOVA INC MNOV · Entity 7011 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 56,250 | $0.00 Strike: $2.46 | $0.00 |
DisclosureSEC source: 0001683168-21-002744 · ownership.xml · derivative · entry 4 Matsuda Kazuko · CIK 0001531140 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 56,250 shares Expires 2021-08-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option was granted on 8/3/2011, was subject to vesting based on achievement of performance criteria and vested in full on 6/14/2012. Read SEC document |
| June 24, 2021 Filed Jun 28, 2021 20:50 UTC | MEDICINOVA INC MNOV · Entity 7011 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 46,554 | $0.00 Strike: $2.54 | $0.00 |
DisclosureSEC source: 0001683168-21-002744 · ownership.xml · derivative · entry 3 Matsuda Kazuko · CIK 0001531140 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 46,554 shares Expires 2021-07-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option vested over a period of 4 years in equal monthly installments from the 7/13/2011 date of grant and is now fully vested. Read SEC document |
| June 24, 2021 Filed Jun 28, 2021 20:50 UTC | MEDICINOVA INC MNOV · Entity 7011 | Exercise / conversionCommon Stock | 56,250 | $2.46 | $138,375.00 |
DisclosureSEC source: 0001683168-21-002744 · ownership.xml · nonDerivative · entry 2 Matsuda Kazuko · CIK 0001531140 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 262,996 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 24, 2021 Filed Jun 28, 2021 20:50 UTC | MEDICINOVA INC MNOV · Entity 7011 | Exercise / conversionCommon Stock | 46,554 | $2.54 | $118,247.16 |
DisclosureSEC source: 0001683168-21-002744 · ownership.xml · nonDerivative · entry 1 Matsuda Kazuko · CIK 0001531140 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 206,746 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 02, 2021 Filed Feb 4, 2021 21:16 UTC | MEDICINOVA INC MNOV · Entity 7011 | GrantEmployee Stock Option (Right to Buy) · Derivative | 325,000 | $0.00 Strike: $6.89 | $0.00 |
DisclosureSEC source: 0001683168-21-000392 · ownership.xml · derivative · entry 1 Matsuda Kazuko · CIK 0001531140 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 325,000 Underlying: Common Stock · 325,000 shares Expires 2030-01-08 F1 · balance_after: On January 9, 2020, the reporting person was granted an option to purchase 325,000 shares of common stock. The option vests based on the satisfaction of certain performance criteria for the fiscal year ended December 31, 2020. Such performance criteria for 2020 have been met, resulting in full vesting of the option. Read SEC document |
| June 12, 2020 Filed Jun 15, 2020 21:02 UTC | MEDICINOVA INC MNOV · Entity 7011 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $5.13 | $0.00 |
DisclosureSEC source: 0001683168-20-001952 · ownership.xml · derivative · entry 2 Matsuda Kazuko · CIK 0001531140 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2020-06-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option vested over a period of 4 years in equal monthly installments from the 6/14/2010 date of grant and is now fully vested. Read SEC document |
| June 12, 2020 Filed Jun 15, 2020 21:02 UTC | MEDICINOVA INC MNOV · Entity 7011 | Exercise / conversionCommon Stock | 20,000 | $5.13 | $102,600.00 |
DisclosureSEC source: 0001683168-20-001952 · ownership.xml · nonDerivative · entry 1 Matsuda Kazuko · CIK 0001531140 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,192 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 08, 2020 Filed Apr 14, 2020 01:42 UTC | MEDICINOVA INC MNOV · Entity 7011 | Exercise / conversionEmployee Stock option (Right to Buy) · Derivative | 28,446 | $0.00 Strike: $2.54 | $0.00 |
DisclosureSEC source: 0001683168-20-001158 · ownership.xml · derivative · entry 2 Matsuda Kazuko · CIK 0001531140 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,554 Underlying: Common stock · 28,446 shares Expires 2021-07-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option vested over a period of 4 years in equal monthly installments from the 7/13/2011 date of grant and is now fully vested. Read SEC document |
| April 08, 2020 Filed Apr 14, 2020 01:42 UTC | MEDICINOVA INC MNOV · Entity 7011 | Exercise / conversionCommon Stock | 28,446 | $2.54 | $72,252.84 |
DisclosureSEC source: 0001683168-20-001158 · ownership.xml · nonDerivative · entry 1 Matsuda Kazuko · CIK 0001531140 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,192 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 13, 2020 Filed Mar 13, 2020 21:53 UTC | MEDICINOVA INC MNOV · Entity 7011 | PurchaseCommon Stock | 2,000 | $3.62 | $7,240.00 |
DisclosureSEC source: 0001683168-20-000807 · ownership.xml · nonDerivative · entry 1 Matsuda Kazuko · CIK 0001531140 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,476 F1 · balance_after: The reported shares were purchased in multiple transactions. The purchase price reported in Column 4 is a weighted average price ranging from $3.54 to $3.69. The reporting person undertakes to provide to MediciNova, Inc., any security holder of MediciNova, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F2 · balance_after: Includes 289 shares acquired under MediciNova's employee stock purchase plan, which are exempt under Rule 16b-3(c). Read SEC document |
| March 13, 2020 Filed Mar 16, 2020 23:17 UTC Amendment | MEDICINOVA INC MNOV · Entity 7011 | PurchaseCommon Stock | 2,000 | $3.62 | $7,240.00 |
DisclosureSEC source: 0001683168-20-000840 · ownership.xml · nonDerivative · entry 1 Matsuda Kazuko · CIK 0001531140 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,746 F1 · price: The reported shares were purchased in multiple transactions. The purchase price reported in Column 4 is a weighted average price ranging from $3.54 to $3.69. The reporting person undertakes to provide to MediciNova, Inc., any security holder of MediciNova, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F2 · balance_after: Includes 289 shares acquired under MediciNova's employee stock purchase plan, which are exempt under Rule 16b-3(c). F3 · balance_after: This report is being amended to correct the amount of securities beneficially owned in Column 5. Read SEC document |
| January 09, 2020 Filed Jan 11, 2020 01:03 UTC | MEDICINOVA INC MNOV · Entity 7011 | GrantEmployee Stock Option (Right to Buy) · Derivative | 243,750 | $0.00 Strike: $9.67 | $0.00 |
DisclosureSEC source: 0001683168-20-000088 · ownership.xml · derivative · entry 1 Matsuda Kazuko · CIK 0001531140 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 243,750 Underlying: Common Stock · 243,750 shares Expires 2029-01-14 F1 · balance_after: On January 15, 2019, the reporting person was granted an option to purchase 325,000 shares of common stock. The option vests based on MNOV's satisfaction of certain performance criteria for the fiscal year ended December 31, 2019. The performance criterial for 2019 were achieved at the 75% attainment level, resulting in vesting of the option as to 243,750 shares. Read SEC document |
| June 12, 2019 Filed Jun 13, 2019 21:06 UTC | MEDICINOVA INC MNOV · Entity 7011 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 37,000 | $0.00 Strike: $4.80 | $0.00 |
DisclosureSEC source: 0001683168-19-001890 · ownership.xml · derivative · entry 2 Matsuda Kazuko · CIK 0001531140 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 37,000 shares Expires 2019-07-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested over a period of 4 years in equal monthly installments from the 7/7/2009 date of grant and is now fully vested. Read SEC document |
| June 12, 2019 Filed Jun 13, 2019 21:06 UTC | MEDICINOVA INC MNOV · Entity 7011 | Exercise / conversionCommon Stock | 37,000 | $4.80 | $177,600.00 |
DisclosureSEC source: 0001683168-19-001890 · ownership.xml · nonDerivative · entry 1 Matsuda Kazuko · CIK 0001531140 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,457 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 10,454 shares acquired under MediciNova's employee stock purchase plan, which are exempt under Rule 16b-3(c). Read SEC document |
| January 15, 2019 Filed Jan 17, 2019 21:23 UTC | MEDICINOVA INC MNOV · Entity 7011 | GrantEmployee Stock Option (Right to Buy) · Derivative | 295,000 | $0.00 Strike: $7.00 | $0.00 |
DisclosureSEC source: 0001683168-19-000148 · ownership.xml · derivative · entry 1 Matsuda Kazuko · CIK 0001531140 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 295,000 Underlying: Common Stock · 295,000 shares Expires 2028-01-05 F1 · balance_after: On January 6, 2018, the reporting person was granted an option to purchase 295,000 shares of common stock. The option vests based on MNOV's satisfaction of certain performance criteria for the fiscal year ended December 31, 2018. The Performance criteria for 2018 have been met, resulting in full vesting of the option. Read SEC document |
| January 06, 2018 Filed Jan 9, 2018 23:23 UTC | MEDICINOVA INC MNOV · Entity 7011 | GrantEmployee Stock Option (Right to Buy) · Derivative | 280,000 | $0.00 Strike: $6.10 | $0.00 |
DisclosureSEC source: 0001683168-18-000089 · matsuda_f4-010618.xml · derivative · entry 1 Matsuda Kazuko · CIK 0001531140 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 280,000 Underlying: Common Stock · 280,000 shares Expires 2027-01-17 F1 · balance_after: On January 18, 2017, the reporting person was granted an option to purchase 280,000 shares of common stock. The option vests based on MNOV's satisfaction of certain performance criteria for the fiscal year ended December 31, 2017. The Performance criteria for 2017 have been met, resulting in full vesting of the option. Read SEC document |
| January 18, 2017 Filed Jan 20, 2017 22:29 UTC | MEDICINOVA INC MNOV · Entity 7011 | GrantEmployee Stock Option (Right to Buy) · Derivative | 170,000 | $0.00 Strike: $3.91 | $0.00 |
DisclosureSEC source: 0001683168-17-000139 · matsuda_f4.xml · derivative · entry 1 Matsuda Kazuko · CIK 0001531140 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170,000 Underlying: Common Stock · 170,000 shares Expires 2026-01-06 F1 · balance_after: On January 7, 2016, the reporting person was granted an option to purchase 170,000 shares of common stock. The option vests based on MNOV's satisfaction of certain performance criteria by December 31, 2016. The Performance criteria have been met, resulting in full vesting of the option. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.